Vbi Vaccines Stock Analysis

VBIV Stock  USD 0.63  0.02  3.28%   
VBI Vaccines is undervalued with Real Value of 1.46 and Target Price of 4.0. The main objective of VBI Vaccines stock analysis is to determine its intrinsic value, which is an estimate of what VBI Vaccines is worth, separate from its market price. There are two main types of VBI Vaccines' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect VBI Vaccines' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of VBI Vaccines' stock to identify patterns and trends that may indicate its future price movements.
The VBI Vaccines stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. VBI Vaccines is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. VBI Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and VBI Vaccines' ongoing operational relationships across important fundamental and technical indicators.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.

VBI Stock Analysis Notes

The company has Price to Book (P/B) ratio of 0.82. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. VBI Vaccines recorded a loss per share of 6.03. The entity last dividend was issued on the 28th of December 2012. The firm had 1:30 split on the 12th of April 2023. VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts. Vbi Vaccines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 149 people. For more information please call Curtis Lockshin at 617 830 3031 or visit https://www.vbivaccines.com.

VBI Vaccines Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. VBI Vaccines' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding VBI Vaccines or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
VBI Vaccines had very high historical volatility over the last 90 days
VBI Vaccines has some characteristics of a very speculative penny stock
VBI Vaccines has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 8.68 M. Net Loss for the year was (92.84 M) with loss before overhead, payroll, taxes, and interest of (10.19 M).
VBI Vaccines currently holds about 82.41 M in cash with (60.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32.
VBI Vaccines has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Individual investors account for 55 percent of VBI Vaccines Inc.s ownership, while private equity firms ... - Yahoo Movies UK

VBI Vaccines Upcoming and Recent Events

Earnings reports are used by VBI Vaccines to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to VBI Vaccines previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
11th of March 2024
Upcoming Quarterly Report
20th of May 2024
Next Financial Report
31st of December 2023
Next Fiscal Quarter End
11th of March 2024
Next Fiscal Year End
30th of September 2023
Last Quarter Report
31st of December 2022
Last Financial Announcement

VBI Largest EPS Surprises

Earnings surprises can significantly impact VBI Vaccines' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

VBI Vaccines Thematic Classifications

In addition to having VBI Vaccines stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products Idea
Pharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

VBI Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as VBI Vaccines is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading VBI Vaccines backward and forwards among themselves. VBI Vaccines' institutional investor refers to the entity that pools money to purchase VBI Vaccines' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Alpine Partners Vi, Llc2023-12-31
25 K
Two Sigma Securities, Llc2023-12-31
24.6 K
Millennium Management Llc2023-12-31
22 K
Warberg Asset Management Llc2023-12-31
15 K
Captrust Financial Advisors2023-12-31
12.3 K
Steward Partners Investment Advisory, Llc2023-12-31
3.1 K
Royal Bank Of Canada2023-12-31
1.4 K
Newbridge Financial Services Group, Inc.2023-12-31
1.2 K
Wetzel Investment Advisors Inc2023-12-31
Perceptive Advisors Llc2023-12-31
1.4 M
Alyeska Investment Group, L.p.2023-09-30
696.7 K
Note, although VBI Vaccines' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

VBI Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate VBI Vaccines's market, we take the total number of its shares issued and multiply it by VBI Vaccines's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

VBI Profitablity

VBI Vaccines' profitability indicators refer to fundamental financial ratios that showcase VBI Vaccines' ability to generate income relative to its revenue or operating costs. If, let's say, VBI Vaccines is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, VBI Vaccines' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of VBI Vaccines' profitability requires more research than a typical breakdown of VBI Vaccines' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.88)(1.79)
Return On Capital Employed(4.93)(4.69)
Return On Assets(1.07)(1.12)
Return On Equity(12.33)(11.72)

Management Efficiency

VBI Vaccines has return on total asset (ROA) of (0.2857) % which means that it has lost $0.2857 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.5899) %, meaning that it created substantial loss on money invested by shareholders. VBI Vaccines' management efficiency ratios could be used to measure how well VBI Vaccines manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to -1.79 in 2024. Return On Capital Employed is likely to climb to -4.69 in 2024. At this time, VBI Vaccines' Other Current Assets are fairly stable compared to the past year. Intangible Assets is likely to climb to about 47.5 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 42.9 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 0.48  0.46 
Net Current Asset Value35.3 M37.1 M
Tangible Asset Value72.9 M76.5 M
Tangible Book Value Per Share(1.93)(1.84)
Enterprise Value Over EBITDA(0.72)(0.76)
Price Book Value Ratio 1.22  0.66 
Enterprise Value Multiple(0.72)(0.76)
Price Fair Value 1.22  0.66 
Enterprise Value38.5 M57 M
The analysis of VBI Vaccines' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze VBI Vaccines' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of VBI Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.

Technical Drivers

As of the 21st of April, VBI Vaccines has the Downside Deviation of 7.78, market risk adjusted performance of 0.4628, and Risk Adjusted Performance of 0.0317. In connection with fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of VBI Vaccines, as well as the relationship between them. In other words, you can use this information to find out if the entity will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for VBI Vaccines, which can be compared to its competition. Please validate VBI Vaccines coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if VBI Vaccines is priced adequately, providing market reflects its prevalent price of 0.63 per share. As VBI Vaccines is a penny stock we also advise to double-check its total risk alpha numbers.

VBI Vaccines Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. VBI Vaccines middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for VBI Vaccines. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

VBI Vaccines Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific VBI Vaccines insiders, such as employees or executives, is commonly permitted as long as it does not rely on VBI Vaccines' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases VBI Vaccines insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

VBI Vaccines Predictive Daily Indicators

VBI Vaccines intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of VBI Vaccines stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

VBI Vaccines Forecast Models

VBI Vaccines' time-series forecasting models are one of many VBI Vaccines' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary VBI Vaccines' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About VBI Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how VBI Vaccines prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling VBI shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as VBI Vaccines. By using and applying VBI Stock analysis, traders can create a robust methodology for identifying VBI entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(10.69)(11.23)
Operating Profit Margin(6.37)(6.69)
Net Loss(10.69)(11.23)
Gross Profit Margin(0.67)(0.70)

Current VBI Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. VBI analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. VBI analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
VBI Vaccines current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most VBI analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand VBI stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of VBI Vaccines, talking to its executives and customers, or listening to VBI conference calls.
VBI Analyst Advice Details

VBI Stock Analysis Indicators

VBI Vaccines stock analysis indicators help investors evaluate how VBI Vaccines stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading VBI Vaccines shares will generate the highest return on investment. By understating and applying VBI Vaccines stock analysis, traders can identify VBI Vaccines position entry and exit signals to maximize returns.
Begin Period Cash Flow62.6 M
Common Stock Shares Outstanding15.6 M
Total Stockholder Equity7.5 M
Property Plant And Equipment Net11.9 M
Cash And Short Term Investments23.7 M
Cash23.7 M
Accounts Payable6.4 M
Net Debt29.4 M
50 Day M A0.6146
Total Current Liabilities75.7 M
Other Operating Expenses64 M
Non Current Assets Total50.7 M
Non Currrent Assets Other1.2 M
Stock Based Compensation6.7 M
When determining whether VBI Vaccines is a strong investment it is important to analyze VBI Vaccines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact VBI Vaccines' future performance. For an informed investment choice regarding VBI Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for VBI Stock analysis

When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.